Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
09/2000
09/27/2000EP0885188B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
09/21/2000WO2000055138A1 Method of producing oxcarbazepine (=10,11- dihydro- 10- oxo- 5h- dibenz(b,f)- azepine- 5- carboxamide) and its intermediate products
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000054759A2 Lxr modulators
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000CA2367895A1 Compounds and methods for modulation of estrogen receptors
09/21/2000CA2367595A1 Lxr modulators
09/14/2000WO1999063999A8 H1-histamine receptor antagonists
09/14/2000DE19910504A1 Verfahren zur Reinigung von N-substituierten Lactamen A process for purifying N-substituted lactams
09/13/2000EP1033988A1 Parenteral formulations comprising carbamazepine or its derivatives
09/13/2000EP0983248A4 Analogs of duocarmycin and cc-1065
09/13/2000EP0778883B1 Quarternary substituted bleach activators
09/13/2000EP0641439B1 Reagents and methods for the quantification of imipramine or desipramine in biological fluids
09/13/2000EP0599935B1 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids
09/12/2000US6118010 Catalytic reduction of the 1-alkoxycarbonyl-3-oxo-3-phenylpropyl derivative
09/12/2000US6117870 Cyclic amide derivatives
09/12/2000US6117866 For inhibiting platelet aggregation or clot formation and reocclusion of an artery or vein in a mammal following fibrinolytic therapy or angioplasty; for treating stroke, transient ischemia attacks, or myocardial infarction
09/07/2000DE19910403A1 Medicaments containing hydroxy-benzo-cyclopentabenzazepine-dione derivatives, useful as cellular hyperproliferation inhibitors, especially antitumor agents
09/07/2000DE10010189A1 Production of caprolactam, used in nylon manufacture, comprises gas-phase rearrangement of cyclohexanone oxime on a silica or zeolite catalyst treated or reactivated with acid
09/06/2000EP1032556A1 Pharmaceutically active compounds and methods of use
09/06/2000EP1032394A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
09/05/2000US6114390 An argininamide or ornithinamide compound as treating memory loss, migraine, sleep disorders, pain, cardiovascular diseases, subarachnoidal bleeding, vascular-hypertrophic changes, cerebral and coronary vasospasms
08/2000
08/30/2000EP1030840A1 Cyclic amine derivatives and their use as drugs
08/30/2000CN1265109A Thiazolobenzoheterocycles, prepn. and medicines containing same
08/29/2000US6110934 Substituted benzamide derivatives and their use as anticonvulsants
08/29/2000US6110913 N-substituted azaheterocyclic carboxylic acids and esters thereof
08/24/2000WO2000049000A1 Dopamine d1 receptor agonist compounds
08/24/2000WO2000048984A1 Process to separate linear alkyl 5-formylvalerate
08/24/2000WO2000048974A1 Stabilised compositions of o- and n-vinyl compounds and the use of ammonium salts as stabilisers
08/24/2000WO2000048601A1 Medicament for treating hypertension
08/24/2000WO2000015992A3 Tube for lining pipes and channels, and a method and device for the production thereof
08/24/2000CA2363695A1 Dopamine d1 receptor agonist compounds
08/23/2000EP1029848A1 Process to separate linear alkyl 5-formylvalerate
08/23/2000CN1264300A Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia
08/22/2000US6107291 Antiinflammatory agent
08/17/2000WO2000047563A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000WO2000047207A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000DE19906316A1 Polymerizable vinyl compositions are stabilized by the addition of optionally substituted ammonium carbonate salts
08/17/2000DE19906310A1 Use of 3-(1-(2-aralkyl-2-carboxyethyl)-1-cyclopentanecarboxamido)-2,3,4,5-tetrahydro-2-oxo-1H-benz(b)azepine-1-acetic acid derivatives for treating hypertension
08/17/2000CA2361919A1 Lactam inhibitors of fxa and method
08/17/2000CA2360305A1 Lactam inhibitors of fxa and method
08/16/2000EP1028108A1 Process for producing epsilon-caprolactam
08/16/2000EP1027337A1 Integrin receptor antagonists
08/16/2000EP0847390B1 A PROCESS FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ(b,f)AZEPIN-5-CARBOXAMIDE
08/16/2000CN1055403C Medical ointment for treating scabies
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/09/2000EP1026158A1 Process for the preparation of 5-carbamoyl-5H-dibenz(b,f)azepine
08/09/2000EP1025087A1 Substituted isoquinoline derivatives and their use as anticonvulsants
08/09/2000CN1262618A NF-KB inhibitors containing as active ingredient phenylmethyl benzoquinone
08/08/2000CA2019053C Curable powder coating compositions containing caprolactam-blocked isocyanates
08/02/2000EP1023073A1 Vitronectin receptor antagonist
08/01/2000US6096885 Exhibit agonist activity for cck-a receptors thereby enabling them to modulate the hormones gastrin and cholecystokinin in mammals.
08/01/2000US6096736 Benzazepine derivatives with vasopressin agonistic activity
08/01/2000US6096735 Benzoheterocyclic derivatives
08/01/2000CA2015034C Piperazine derivatives
07/2000
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000WO1999062881A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
07/26/2000EP1021190A1 Novel amide derivatives
07/26/2000EP1021189A1 Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation
07/20/2000WO2000042040A1 Tricyclic inhibitors of poly(adp-ribose) polymerases
07/19/2000EP1020470A2 Galanthamine derivatives, a process for their preparation and their use as medicaments
07/19/2000EP1020469A2 Galanthamine derivatives, a process for their preparation and their use as medicaments
07/19/2000EP1019383A2 Process for the aminocarbonylation of benzazepines and benzodiazepines
07/19/2000EP1019367A1 Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use
07/19/2000EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/13/2000WO2000040577A1 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12
07/13/2000WO2000040564A1 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
07/13/2000CA2358955A1 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
07/13/2000CA2356689A1 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12
07/12/2000CN1054380C Condensed cyclic compounds and their use
07/06/2000WO2000039085A1 Process for the production of n-vinyl-2-pyrrolidone by vinylation
07/06/2000WO2000039077A2 Thyroid receptor ligands
07/06/2000WO2000038687A1 Protease inhibitors
07/06/2000WO2000038618A2 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
07/06/2000WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS
07/06/2000CA2356671A1 Protease inhibitors
07/06/2000CA2356319A1 Thyroid receptor ligands
07/06/2000CA2347671A1 Succinoylamino benzodiazepines as inhibitors of a.beta. protein production
07/05/2000EP1015425A1 Caprolactam production process
07/05/2000EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
07/05/2000EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
07/05/2000CN1259119A Substituted 3,3-diamino-2-propenenitriles their preparation and use
07/05/2000CN1054125C Process for producing imino-sym-phenylethylene by catalytic dehydrogenation with imido-bibenzil
06/2000
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/28/2000EP1011679A1 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
06/27/2000CA2161214C Bleaching compounds comprising substituted benzoyl caprolactam bleach activators
06/21/2000EP1009405A1 Pyrrolidine and piperidine modulators of chemokine receptor activity
06/21/2000EP0888436B1 Solid composition of heterocyclic compounds and/or oxime esters and inert porous carrier materials
06/21/2000CN1257485A Azacyclooctane and heptane derivatives, their preparation and usein therapy
06/20/2000US6077955 Preparation of lactams from aliphatic αω-dinitriles
06/15/2000WO2000033788A2 Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
06/15/2000CA2355296A1 Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
06/14/2000EP1008592A2 Cyclic amide derivatives which inhibit cathepsin K
06/14/2000EP1008346A1 NF-$g(k)B INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT PHENYLMETHYL BENZOQUINONE
06/14/2000EP1007051A1 Integrin receptor antagonists
06/08/2000WO2000033617A1 Oleds containing thermally stable glassy organic hole transporting materials
06/06/2000US6071915 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
06/06/2000US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases
06/06/2000US6071901 Treating pain, hyperalgesia and/or inflammatory conditions in which c-fibers play a pathophysiological role; inhibition of neurogenic inflammation involving the release of neuro-peptide from peripheral and central endings of sensory nerves
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 88